1. Home
  2. FSHP vs PMVP Comparison

FSHP vs PMVP Comparison

Compare FSHP & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FSHP
  • PMVP
  • Stock Information
  • Founded
  • FSHP 2018
  • PMVP 2013
  • Country
  • FSHP United States
  • PMVP United States
  • Employees
  • FSHP N/A
  • PMVP N/A
  • Industry
  • FSHP
  • PMVP Medicinal Chemicals and Botanical Products
  • Sector
  • FSHP
  • PMVP Health Care
  • Exchange
  • FSHP NYSE
  • PMVP Nasdaq
  • Market Cap
  • FSHP 90.8M
  • PMVP 85.5M
  • IPO Year
  • FSHP 2024
  • PMVP 2020
  • Fundamental
  • Price
  • FSHP $10.23
  • PMVP $1.36
  • Analyst Decision
  • FSHP
  • PMVP Strong Buy
  • Analyst Count
  • FSHP 0
  • PMVP 3
  • Target Price
  • FSHP N/A
  • PMVP $5.33
  • AVG Volume (30 Days)
  • FSHP 7.5K
  • PMVP 132.0K
  • Earning Date
  • FSHP 01-01-0001
  • PMVP 02-27-2025
  • Dividend Yield
  • FSHP N/A
  • PMVP N/A
  • EPS Growth
  • FSHP N/A
  • PMVP N/A
  • EPS
  • FSHP 0.11
  • PMVP N/A
  • Revenue
  • FSHP N/A
  • PMVP N/A
  • Revenue This Year
  • FSHP N/A
  • PMVP N/A
  • Revenue Next Year
  • FSHP N/A
  • PMVP N/A
  • P/E Ratio
  • FSHP $90.08
  • PMVP N/A
  • Revenue Growth
  • FSHP N/A
  • PMVP N/A
  • 52 Week Low
  • FSHP $9.99
  • PMVP $1.32
  • 52 Week High
  • FSHP $10.25
  • PMVP $2.26
  • Technical
  • Relative Strength Index (RSI)
  • FSHP N/A
  • PMVP 37.63
  • Support Level
  • FSHP N/A
  • PMVP $1.37
  • Resistance Level
  • FSHP N/A
  • PMVP $1.46
  • Average True Range (ATR)
  • FSHP 0.00
  • PMVP 0.04
  • MACD
  • FSHP 0.00
  • PMVP 0.00
  • Stochastic Oscillator
  • FSHP 0.00
  • PMVP 9.09

About FSHP FLAG SHIP ACQUISITION CORPORATION

Flag Ship Acquisition Corp is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

About PMVP PMV Pharmaceuticals Inc.

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.

Share on Social Networks: